Vanguard Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.44B Sell
14,058,204
-287,255
-2% -$107M 0.12% 134
2026
Q1
$4.2B Buy
+14,345,459
New +$4.71B 0.1% 173

Other funds holding ELV

Vanguard Capital Management's ELV Position: Q2 2026 in Review

Vanguard Capital Management reduced its Elevance Health (ELV) stake by 2% in Q2 2026, selling an estimated $107M and leaving 14,058,204 shares worth $5.44B. The position accounts for 0.12% of the portfolio, ranked #134.

Vanguard Capital Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vanguard Capital Management held 14,058,204 shares of Elevance Health worth $5.44B as of Q2 2026.
  • Vanguard Capital Management sold 287,255 Elevance Health shares in Q2 2026, an estimated $107M.
  • Elevance Health made up 0.12% of Vanguard Capital Management's portfolio in Q2 2026, its #134 holding.
  • Vanguard Capital Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.